Rare Events Doesn’t Mean What it Use To

Risk of Myocarditis and other AESI > Risk of COVID Hospitalizations (Part 21)

A multi-Country European Cohort Event Monitoring Study (CEM) (n = 29,837) found that almost three-quarters of vaxxed participants who completed the baseline survey and first follow up questionnaire experienced at least one adverse event following the first or second dose of the primary series or the booster (n = 7,250), while 0.24% and 0.26% experienced a SAEs following any dose of the primary series or booster respectively. While the authors call the percentage of SAEs events “low” that is equivalent to 1 SAE per 400 recipients which is actually much higher than what was seen in the clinical trials following a complete primary series with a median follow-up time of 2 months and is very far from rare unless rare has been redefined to mean less than the majority of recipients but it use to mean 1 in a million or 1 in 100,000 at most having a debilitating reaction not 1 in 400 signal you could find in a high-school population. A long term safety analysis (n = 1,472) of the rare SAEs that occurred following administration of AstraMengele’s adenoviral vector shots that were recently pulled off the market included nearly 4% of recipients developing musculoskeletal disorders and nearly 1% developing hypertension problems. In spite of inoculation, 44% of the vaccine recipients in this prospective observational study contracted COVID19 within one year of their inoculation.

Instead of calling SAEs events rare we can go through the extensive literature that exists to pinpoint the incident rate. I would have added these to my prior answer to the question of what the increased risks of SAEs are but unfortunately Quora sets a character limit on how many studies can be summarized in one answer.

What Are Some Statistics That Show Increased Risks After Getting The COVID Shots